• Ceribell appointed Thomas “Tom” West, Sharon O’Keefe to its board as adoption of its point-of-care brain monitoring platform expands.
• West previously led Nalu Medical as CEO through its sale to Boston Scientific for $600 million in January 2026.
• He also ran Intersect ENT as CEO, leading its sale to Medtronic for $1.1 billion.
• O’Keefe most recently served as president of University of Chicago Medical Center, COO of University of Chicago Medicine, overseeing more than $2 billion annual operating revenue.
• The platform is deployed in more than 680 U.S. hospitals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.